6.
Fowler C, Damm D
. Sialadenoma Papilliferum: Analysis of Seven New Cases and Review of the Literature. Head Neck Pathol. 2017; 12(2):193-201.
PMC: 5953874.
DOI: 10.1007/s12105-017-0852-8.
View
7.
Shimoda M, Kameyama K, Morinaga S, Tanaka Y, Hashiguchi K, Shimada M
. Malignant transformation of sialadenoma papilliferum of the palate: a case report. Virchows Arch. 2004; 445(6):641-6.
DOI: 10.1007/s00428-004-1091-4.
View
8.
Rennie J, MacDonald D, Critchlow H
. Sialadenoma papilliferum. A case report and review of the literature. Int J Oral Surg. 1984; 13(5):452-4.
DOI: 10.1016/s0300-9785(84)80074-5.
View
9.
Abrams A, Finck F
. Sialadenoma papilliferum. A previously unreported salivary gland tumor. Cancer. 1969; 24(5):1057-63.
DOI: 10.1002/1097-0142(196911)24:5<1057::aid-cncr2820240529>3.0.co;2-l.
View
10.
Miyamoto S, Ogawa T, Chikazu D
. Sialadenoma papilliferum in the buccal mucosa detected on F-fluorodeoxyglucose-positron emission tomography. Br J Oral Maxillofac Surg. 2017; 55(7):727-729.
DOI: 10.1016/j.bjoms.2017.05.004.
View
11.
Levinsohn J, Sugarman J, Bilguvar K, McNiff J, Choate K, The Yale Center For Mendelian Genomics
. Somatic V600E BRAF Mutation in Linear and Sporadic Syringocystadenoma Papilliferum. J Invest Dermatol. 2015; 135(10):2536-2538.
PMC: 4567902.
DOI: 10.1038/jid.2015.180.
View
12.
Kronenberg J, Horowitz A, LEVENTON G
. Sialadenoma papilliferum of the parotid gland. J Laryngol Otol. 1989; 103(11):1089-90.
DOI: 10.1017/s0022215100111089.
View
13.
Ohtomo R, Mori T, Shibata S, Tsuta K, Maeshima A, Akazawa C
. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis. Mod Pathol. 2013; 26(8):1041-50.
DOI: 10.1038/modpathol.2013.54.
View
14.
Konstantinova A, Kyrpychova L, Nemcova J, Sedivcova M, Bisceglia M, Kutzner H
. Syringocystadenoma Papilliferum of the Anogenital Area and Buttocks: A Report of 16 Cases, Including Human Papillomavirus Analysis and HRAS and BRAF V600 Mutation Studies. Am J Dermatopathol. 2018; 41(4):281-285.
DOI: 10.1097/DAD.0000000000001285.
View
15.
Hsieh L, Wang P, Chen I, Liao C, Wang H, Chen M
. Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis. 2001; 22(9):1497-503.
DOI: 10.1093/carcin/22.9.1497.
View
16.
Nakaguro M, Urano M, Ogawa I, Hirai H, Yamamoto Y, Yamaguchi H
. Histopathological evaluation of minor salivary gland papillary-cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm. Histopathology. 2019; 76(3):411-422.
DOI: 10.1111/his.13990.
View
17.
Carneiro T, Marinho S, Verli F, Mesquita A, Lima N, Miranda J
. Oral squamous papilloma: clinical, histologic and immunohistochemical analyses. J Oral Sci. 2009; 51(3):367-72.
DOI: 10.2334/josnusd.51.367.
View
18.
Mahajan D, Khurana N, Setia N
. Sialadenoma papilliferum in a young patient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103(3):e51-4.
DOI: 10.1016/j.tripleo.2006.01.012.
View
19.
Hsieh M, Bishop J, Wang Y, Poh C, Cheng Y, Lee Y
. Salivary Sialadenoma Papilliferum Consists of Two Morphologically, Immunophenotypically, and Genetically Distinct Subtypes. Head Neck Pathol. 2019; 14(2):489-496.
PMC: 7235136.
DOI: 10.1007/s12105-019-01068-4.
View
20.
Gomes C, Diniz M, Azevedo Orsine L, Duarte A, Fonseca-Silva T, Conn B
. Assessment of TP53 mutations in benign and malignant salivary gland neoplasms. PLoS One. 2012; 7(7):e41261.
PMC: 3400573.
DOI: 10.1371/journal.pone.0041261.
View